Company Directory / pharmaceuticals
PrivateFor profitpharmaceuticalsNewark, United States
Quark Pharmaceuticals
Quark Pharmaceuticals is a clinical-stage pharmaceutical company engaged in the discovery and development of novel RNAi-based therapeutics.
- Founded
- 1994 32 years ago
- Staff
- 51-100 band, as listed
- Followers
- - on LinkedIn
- Funding
- $61M as listed, currency not stated
Set against six million companies
Size
51-100 people: larger than 75% of companies with a size listed
Age
32 years old.
Reach
Website ranked #8,958,753 in the world for traffic, about 445 visits a month.
What it does
BiotechnologyClinical TrialsGeneticsMedical
Funding, as listed
$61M currency not stated
- Rounds5
- LatestSeries unknown, Jun 2010
- Investors2, 1 leading
What the source datasets report. We have not watched these rounds ourselves.
Every detail we hold
Everything the source datasets list about Quark Pharmaceuticals, field by field. Contact details are held but never shown.
The company
- Name
- Quark Pharmaceuticals
- Type
- For profit
- Status
- Private
- Founded
- 1994
- Founders
- Daniel Zurr
- Industry
- pharmaceuticals
- Categories
- Biotechnology, Clinical Trials, Genetics, Medical
Where
- City
- Newark
- Country
- United States
- Markets
- San Francisco Bay Area, Silicon Valley, West Coast, Western US
Size and reach
- Staff band
- 51-100
- Web traffic rank
- #8,958,753
- Monthly web visits
- 445
Funding, as listed
- Total
- 61,399,000 (currency not stated)
- Rounds
- 5
- Latest round
- Series unknown
- Latest round date
- Jun 2010
- Investors
- 2
- Lead investors
- 1
- Listing status
- private
About this record
- Sources
- Crunchbase
- Last imported
- Sept 2026
Growth, as the source summarises it
Quark Pharmaceuticals may be growing as it is mentioned in the context of the RNA Based Therapeutics Market, which is indicative of its active participation in a relevant and specialized market segment. The company's inclusion in a market insights report suggests that it is a recognized player in the RNA-based therapeutics space, which is a positive indicator of its market presence and potential for growth. Furthermore, being listed alongside other industry players in a report that provides key insights into the market suggests that Quark Pharmaceuticals is involved in the competitive landscape of RNA therapeutics, which is a rapidly evolving and innovative field within the biotechnology and medical industries.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
pharmaceuticals in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.